Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 718 clinical trials in Bilthoven, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)A study of navenibart for long-term safety in patients with hereditary angioedema
The NetherlandsA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
The NetherlandsA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
The NetherlandsA study testing duvakitug for patients with moderately to severely active ulcerative colitis
The NetherlandsStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
The NetherlandsStudy of icotrokinra for adults with moderately to severely active Crohn's disease
The NetherlandsStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
The NetherlandsLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
The NetherlandsStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
The NetherlandsStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
The NetherlandsStudy of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden
The NetherlandsStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on optimizing vaccine effectiveness against multiple infectious diseases, including studies on meningococcal disease and influenza in different age groups.
Novel approaches include investigating optimal vaccination timing and early immunization strategies for enhanced protection.
Advanced studies in breast cancer treatment, examining innovative therapeutic combinations for hormone receptor-positive cases.
Investigations focus on optimizing treatment sequences to improve progression-free survival rates.
Clinical research examining surgical treatments combined with antibiotic therapy for improved patient outcomes.
Studies aim to enhance surgical outcomes through innovative combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
